Related Experiment Videos

Improved growth velocity with intensive dialysis. Consequence or coincidence?

A Katz1, G H Bock, M Mauer

  • 1Department of Pediatrics, University of Minnesota, Minneapolis 55455-0392, USA.

Pediatric Nephrology (Berlin, Germany)
|August 24, 2000
PubMed

Insights

Intensive dialysis in an infant with end-stage renal disease and primary hyperoxaluria type I led to significant growth acceleration. This suggests dialysis dose may be crucial for growth in pediatric kidney failure patients.

Area of Science:

  • Pediatric Nephrology
  • Renal Disease Research
  • Metabolic Disorders

Background:

  • Growth failure is a significant challenge in children with end-stage renal disease (ESRD).
  • Primary hyperoxaluria type I is a rare genetic disorder leading to oxalate accumulation and kidney damage.
  • Optimizing growth in infants with ESRD requires innovative treatment strategies.

Observation:

  • A 2.5-month-old infant with ESRD due to primary hyperoxaluria type I underwent intensive dialysis.
  • The dialysis regimen focused on reducing oxalate deposition in tissues.
  • The infant was monitored over a 5.5-month period while awaiting a kidney transplant.

Findings:

  • The infant exhibited a remarkable growth velocity of 29 cm/year.
  • This growth rate significantly surpassed that of infants on standard hemodialysis (4 cm/year) and normal infants (22 cm/year).
  • The accelerated growth is hypothesized to be linked to the intensive dialysis regimen and its effect on oxalate accretion.

Implications:

  • Intensive dialysis may promote catch-up growth in pediatric ESRD patients.
  • The delivered dialysis dose could be a critical factor influencing growth in this population.
  • Further investigation through prospective randomized trials is warranted to confirm this relationship and optimize treatment protocols.

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...